Table 1. Correlation between the expression of DSG2 and the clinicopathological characteristics of the lung adenocarcinoma patients.
| Clinicopathological features | n | Mean ± SD | p-value | |
|---|---|---|---|---|
| Age (years) | <60 ≥60 |
23 17 |
0.089 ± 0.074 0.092 ± 0.084 |
0.845 |
| Gender | Male Female |
18 22 |
0.080 ± 0.058 0.099 ± 0.090 |
0.973 |
| Smoking history | No Yes |
24 16 |
0.099 ± 0.086 0.077 ± 0.058 |
0.759 |
| TNM tumor stage | I+II III+IV |
23 17 |
0.063 ± 0.040 0.128 ± 0.098 |
0.023* |
| Tumor size (cm) | ≤3 >3 |
13 27 |
0.052 ± 0.027 0.109 ± 0.087 |
0.027* |
| Lymph node metastasis | No Yes |
15 25 |
0.053 ± 0.034 0.113 ± 0.087 |
0.014* |
Notes.
*
p < 0.05; TNM, tumor-node-metastasis; SD, standard deviation.